Clinical Trial Update: A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating CT-868 in overweight and obese adults with type 2 diabetes mellitus has completed. The study was sponsored by Carmot Therapeut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• CT-868

Snippet

Sponsor: Carmot Therapeutics, Inc. | Conditions: Obesity, Overweight | Phase 2 | Status: COMPLETED